The Coalition for Epidemic Preparedness Innovations (CEPI) will “urgently accelerate” the development of three investigational vaccines targeting the Bundibugyo virus, responsible for the current Ebola outbreak in the Democratic Republic of Congo (DRC) and Uganda, the organisation announced on Monday.
"With Bundibugyo virus spreading rapidly and no licensed vaccines, every day counts in the race against this deadly disease,” said Dr Richard Hatchett, CEPI’s Chief Executive Officer.
